Cargando…

IMRT with Stereotactic Body Radiotherapy Boost for High Risk Malignant Salivary Gland Malignancies: A Case Series

Patients with high risk salivary gland malignancies are at increased risk of local failure. We present our institutional experience with dose escalation using hypofractionated stereotactic body radiotherapy (SBRT) in a subset of this rare disease. Over the course of 9 years, 10 patients presenting w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karam, Sana D., Rashid, Abdul, Snider, James W., Wooster, Margaux, Bhatia, Shilpa, Jay, Ann K., Newkirk, Kenneth, Davidson, Bruce, Harter, William K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204450/ https://www.ncbi.nlm.nih.gov/pubmed/25374840 http://dx.doi.org/10.3389/fonc.2014.00268

Ejemplares similares

Reirradiation of recurrent salivary gland malignancies with fractionated stereotactic body radiation therapy
por: Karam, Sana D., et al.
Publicado: (2012)

Survival Outcomes of Patients Treated with Hypofractionated Stereotactic Body Radiation Therapy for Parotid Gland Tumors: a Retrospective Analysis
por: Karam, Sana D., et al.
Publicado: (2012)

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial
por: Jensen, Alexandra D, et al.
Publicado: (2012)

Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC
por: Jensen, Alexandra D, et al.
Publicado: (2010)

Malignant tumours of the salivary glands
por: Bensadoun, R J, et al.
Publicado: (2001)

The use of stereotactic body radiation therapy for local control of glomangiomatosis: a case report
por: Horne, Zachary D., et al.
Publicado: (2013)

Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity
por: Lang, Kristin, et al.
Publicado: (2018)

Assessing the Usefulness of Salivary Gland Fine Needle Aspiration Cytology as Diagnostic Aid for Salivary gland Malignancy
por: Rooban, T, et al.
Publicado: (2013)

Metachronous malignant tumors in ipsilateral salivary glands
por: Kwon, Hyo Jeong, et al.
Publicado: (2019)

A benign salivary gland tumor of minor salivary gland mimicking an epithelial malignancy
por: Reddy, Vandana, et al.
Publicado: (2015)

Second primary malignancies following salivary gland cancers.
por: Biggar, R. J., et al.
Publicado: (1983)

Malignant mixed tumor in the salivary gland of a cat
por: Kim, Heejaung, et al.
Publicado: (2008)

Systemic therapy for recurrent or metastatic salivary gland malignancies
por: Chintakuntlawar, Ashish V., et al.
Publicado: (2016)

Expression of Paxillin in Benign and Malignant Salivary Gland Tumors
por: Andisheh–Tadbir, Azadeh, et al.
Publicado: (2019)

Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12)
por: Jensen, Alexandra D, et al.
Publicado: (2011)

MTA1 Expression in Benign and Malignant Salivary gland Tumors
por: Andisheh-Tadbir, Azadeh, et al.
Publicado: (2016)

PD-L1 expression in malignant salivary gland tumors
por: Harada, Koji, et al.
Publicado: (2018)

Drug-induced atypical hyperplasia enveloping salivary gland malignancy
por: Narwal, Anjali, et al.
Publicado: (2017)

The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors
por: Pouloudi, Despoina, et al.
Publicado: (2020)

Malignant transformation of salivary gland pleomorphic adenoma: proof of principle
por: Valstar, Matthijs H, et al.
Publicado: (2021)

The Therapeutic Landscape of Salivary Gland Malignancies—Where Are We Now?
por: Cleymaet, Robbert, et al.
Publicado: (2022)

The Combination of Inflammatory Biomarkers as Prognostic Indicator in Salivary Gland Malignancy
por: Abbate, Vincenzo, et al.
Publicado: (2022)

Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors
por: Cao, Shuting, et al.
Publicado: (2022)

Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies
por: Pederson, Aaron W, et al.
Publicado: (2011)

Trigeminal neuralgia treatment outcomes following Gamma Knife radiosurgery with a minimum 3-year follow-up
por: Karam, Sana D., et al.
Publicado: (2013)

Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma
por: Adeberg, Sebastian, et al.
Publicado: (2019)

Refractory trigeminal neuralgia treatment outcomes following CyberKnife radiosurgery
por: Karam, Sana D, et al.
Publicado: (2014)

Salivary Heparanase Level Is a Potential Biomarker to Diagnose and Prognose the Malignant Salivary Gland Tumor
por: Wu, Xiangbing, et al.
Publicado: (2015)

Nuclear hBD-1 accumulation in malignant salivary gland tumours
por: Wenghoefer, M, et al.
Publicado: (2008)

Assessment of TP53 Mutations in Benign and Malignant Salivary Gland Neoplasms
por: Gomes, Carolina Cavaliéri, et al.
Publicado: (2012)

Giant Eccrine Hidradenoma Mimicking a Malignant Tumor of the Salivary Gland
por: Oh, Seung Hyun, et al.
Publicado: (2014)

EZH2 is a sensitive marker of malignancy in salivary gland tumors
por: Hajósi-Kalcakosz, Szofia, et al.
Publicado: (2015)

Increased Mast Cell Counts in Benign and Malignant Salivary Gland Tumors
por: Jaafari-Ashkavandi, Zohreh, et al.
Publicado: (2014)

Malignant salivary gland tumours of the larynx: a single institution review
por: Karatayli-Ozgursoy, S., et al.
Publicado: (2016)

The role of immune surveillance in malignant transformation of benign salivary gland tumors
por: Linxweiler, Maximilian, et al.
Publicado: (2021)

Frameless Fractionated Stereotactic Radiosurgery for Vestibular Schwannomas: A Single-Institution Experience
por: Karam, Sana D., et al.
Publicado: (2013)

A Review of Selected Factors of Salivary Gland Tumour Formation and Malignant Transformation
por: Sowa, Pawel, et al.
Publicado: (2018)

Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors
por: Jeiroodi, Naghmeh, et al.
Publicado: (2017)

Milan System for Reporting Salivary Gland Cytopathology: An Experience with the Implication for Risk of Malignancy
por: Kala, Chayanika, et al.
Publicado: (2019)

Overexpression of CDC7 in malignant salivary gland tumors correlates with tumor differentiation()
por: Jaafari-Ashkavandi, Zohreh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1cmn3bh27odn343a38e2vk9gnb